Physician profile
Tess Crouss
NPI 1780096370
$8,480.07
in general payments reported to CMS, 2019-2025
19 companies · $443 in 2025
The $443 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $428 · 2021: $1,735 · 2022: $967 · 2023: $2,188 · 2024: $1,572 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469 · Travel and Lodging: $711 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.89 |
| Travel and Lodging | $710.81 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,253.91 | 2021-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $1,490.65 | 2021-2025 | Interstim, Altaviva |
| Coloplast Corp | $1,335.60 | 2019-2024 | Altis |
| Abbvie INC. | $913.00 | 2020-2025 | Botox |
| Medtronic USA, INC. | $622.35 | 2019-2020 | |
| Boston Scientific Corporation | $415.12 | 2019-2025 | Upsylon, Advantage System, Solyx Sis System |
| Astellas Pharma US INC | $400.20 | 2019-2025 | Veozah |
| Aspira Women'S Health INC | $255.24 | 2021 | |
| Axonics, INC. | $222.59 | 2022-2023 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $187.92 | 2023-2024 | Gemtesa |
| Ethicon US, LLC | $136.73 | 2021-2023 | Vistaseal, Endopath Xcel, Echelon Flex |
| Coopersurgical, INC. | $68.40 | 2022 | |
| Bluewind Medical | $42.08 | 2024 | Revi |
| Allergan, INC. | $34.70 | 2021 | |
| Therapeuticsmd, INC. | $24.92 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $22.24 | 2021 | |
| Teleflex LLC | $20.80 | 2024 | Solesta |
| Mission Pharmacal Company | $19.96 | 2022 | |
| Pfizer INC. | $13.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tess Crouss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.